Skip to main content

Advertisement

SpringerLink
Log in

An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the benefit of an antimicrobial prophylaxis protocol using rectal swab cultures in patients undergoing transrectal ultrasound (TRUS)-guided prostate biopsy in our Veterans Affairs population.

Methods

Between June 1, 2013, and June 1, 2014, we implemented an antimicrobial prophylaxis protocol using rectal swab cultures on selective media containing ciprofloxacin for all men scheduled for TRUS-guided prostate biopsy. Data from 2759 patients from Jan 1, 2006 to May 31, 2013, before protocol implementation served as historical controls. Patients with fluoroquinolone (FQ)-susceptible organisms received FQ monotherapy, while those with FQ-resistant organisms received targeted prophylaxis. Our objective was to compare the rate of infectious complications 30 days after prostate biopsy before and after implementation of our antimicrobial protocol.

Results

One hundred and sixty-seven patients received rectal swab cultures using our protocol. Seventeen (14 %) patients had FQ-resistant positive cultures. Patients with positive FQ-resistant culture results were more likely to have had a history of previous prostate biopsy and a positive urine culture in the last 12 months (p = 0.032, p = 0.018, respectively). The average annual infectious complication rate within 30 days of biopsy was reduced from 2.8 to 0.6 % before and after implementation of our antimicrobial prophylaxis protocol using rectal swab cultures, although this difference was not statistically significant (p = 0.13).

Conclusion

An antimicrobial prophylaxis protocol using rectal culture swabs is a viable option for prevention of TRUS-guided prostate biopsy infectious complications. After implementation of an antimicrobial prophylaxis protocol, we observed a nonsignificant decrease in the rate of post-biopsy infectious complications when compared to historical controls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. U.S. Cancer Statistics Working Group (2014) United States Cancer Statistics: 1999–2011 incidence and mortality web-based report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute

  2. Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, Rosario DJ, Scattoni V, Lotan Y (2013) Systematic review of complications of prostate biopsy. Eur Urol 64(6):876–892. doi:10.1016/j.eururo.2013.05.049

    Article  PubMed  Google Scholar 

  3. Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179(4):1379–1390. doi:10.1016/j.juro.2008.01.068

    Article  PubMed  Google Scholar 

  4. Zani EL, Clark OA, Rodrigues Netto N Jr (2011) Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev 5:6576. doi:10.1002/14651858.CD006576.pub2

    Google Scholar 

  5. Liss MA, Chang A, Santos R, Nakama-Peeples A, Peterson EM, Osann K, Billimek J, Szabo RJ, Dash A (2011) Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 185(4):1283–1288. doi:10.1016/j.juro.2010.11.088

    Article  PubMed Central  PubMed  Google Scholar 

  6. Liss MA, Taylor SA, Batura D, Steensels D, Chayakulkeeree M, Soenens C, Rao GG, Dash A, Park S, Patel N, Woo J, McDonald M, Nseyo U, Banapour P, Unterberg S, Ahlering TE, Van Poppel H, Sakamoto K, Fierer J, Black PC (2014) Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol 192(6):1673–1678. doi:10.1016/j.juro.2014.06.005

    Article  PubMed  Google Scholar 

  7. Taylor S, Margolick J, Abughosh Z, Goldenberg SL, Lange D, Bowie WR, Bell R, Roscoe D, Machan L, Black P (2013) Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int 111(6):946–953. doi:10.1111/j.1464-410X.2012.11637.x

    Article  CAS  PubMed  Google Scholar 

  8. Cohen JE, Landis P, Trock BJ, Patel HD, Ball MW, Auwaerter PG, Schaeffer E, Carter HB (2014) Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis. J Urol. doi:10.1016/j.juro.2014.08.008

    PubMed Central  Google Scholar 

  9. Qi C, Malczynski M, Schaeffer AJ, Barajas G, Nadler RB, Scheetz MH, Zembower TR (2013) Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy. J Urol 190(6):2026–2032. doi:10.1016/j.juro.2013.05.059

    Article  CAS  PubMed  Google Scholar 

  10. Duplessis CA, Bavaro M, Simons MP, Marguet C, Santomauro M, Auge B, Collard DA, Fierer J, Lesperance J (2012) Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology 79(3):556–561. doi:10.1016/j.urology.2011.09.057

    Article  PubMed  Google Scholar 

  11. Dai J, Leone A, Mermel L, Hwang K, Pareek G, Schiff S, Golijanin D, Renzulli JF 2nd (2015) Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study. Urology 85(1):8–14. doi:10.1016/j.urology.2014.09.035

    Article  PubMed  Google Scholar 

  12. Bruyere F, Malavaud S, Bertrand P, Decock A, Cariou G, Doublet JD, Bernard L, Bugel H, Conquy S, Sotto A, Boiteux JP, Pogu B, Rebillard X, Mongiat-Artus P, Coloby P (2015) Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy. J Urol 193(1):145–150. doi:10.1016/j.juro.2014.07.086

    Article  PubMed  Google Scholar 

  13. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2011) Complications after prostate biopsy: data from SEER-Medicare. J Urol 186(5):1830–1834. doi:10.1016/j.juro.2011.06.057

    Article  PubMed  Google Scholar 

  14. Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, Loblaw DA, Trachtenberg J, Stanimirovic A, Simor AE, Seth A, Urbach DR, Narod SA (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189(1 Suppl):S12–S17. doi:10.1016/j.juro.2012.11.015; discussion S17–S18

    Article  PubMed  Google Scholar 

  15. Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, Cek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE (2013) Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63(3):521–527. doi:10.1016/j.eururo.2012.06.003

    Article  PubMed  Google Scholar 

  16. Lundstrom KJ, Drevin L, Carlsson S, Garmo H, Loeb S, Stattin P, Bill-Axelson A (2014) Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy. J Urol 192(4):1116–1122. doi:10.1016/j.juro.2014.04.098

    Article  PubMed  Google Scholar 

  17. Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D, Murphy AB, Dielubanza E, Schaeffer AJ (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 187(4):1275–1279. doi:10.1016/j.juro.2011.11.115

    Article  CAS  PubMed  Google Scholar 

  18. Suwantarat N, Dumford DM 3rd, Ponce-Terashima R, Kundrapu S, Zabarsky TF, Zhu H, Donskey CJ (2013) Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy. Infect Control Hosp Epidemiol 34(9):973–976. doi:10.1086/671734

    Article  PubMed  Google Scholar 

  19. Liss MA, Nakamura KK, Peterson EM (2013) Comparison of broth enhancement to direct plating for screening of rectal cultures for ciprofloxacin-resistant Escherichia coli. J Clin Microbiol 51(1):249–252. doi:10.1128/jcm.02158-12

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Tsu JH, Ma WK, Chan WK, Lam BH, To KC, To WK, Ng TK, Liu PL, Cheung FK, Yiu MK (2015) Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum beta-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy. Urology 85(1):15–22. doi:10.1016/j.urology.2014.07.078

    Article  PubMed  Google Scholar 

  21. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (2009) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 136(5 Suppl):e28

    CAS  PubMed  Google Scholar 

  22. Kehinde EO, Al-Maghrebi M, Sheikh M, Anim JT (2013) Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate. J Urol 189(3):911–915. doi:10.1016/j.juro.2012.08.237

    Article  CAS  PubMed  Google Scholar 

  23. Adibi M, Hornberger B, Bhat D, Raj G, Roehrborn CG, Lotan Y (2013) Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol 189(2):535–540. doi:10.1016/j.juro.2012.08.194

    Article  PubMed  Google Scholar 

  24. Ozden E, Bostanci Y, Yakupoglu KY, Akdeniz E, Yilmaz AF, Tulek N, Sarikaya S (2009) Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology 74(1):119–123. doi:10.1016/j.urology.2008.12.067

    Article  PubMed  Google Scholar 

  25. Song W, Choo SH, Sung HH, Han DH, Jeong BC, Seo SI, Jeon SS, Lee KS, Lee SW, Lee HM, Choi HY, Jeon HG (2014) Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant escherichia coli infections after prostate biopsy. Urology 84(5):1001–1007. doi:10.1016/j.urology.2014.06.052

    Article  PubMed  Google Scholar 

  26. Tukenmez Tigen E, Tandogdu Z, Ergonul O, Altinkanat G, Gunaydin B, Ozgen M, Sariguzel N, Erturk Sengel B, Odabasi Z, Cek M, Tokuc R, Turkeri L, Mulazimoglu L, Korten V (2014) Outcomes of fecal carriage of extended-spectrum beta-lactamase after transrectal ultrasound-guided biopsy of the prostate. Urology 84(5):1008–1015. doi:10.1016/j.urology.2014.04.060

    Article  PubMed  Google Scholar 

  27. Abughosh Z, Margolick J, Goldenberg SL, Taylor SA, Afshar K, Bell R, Lange D, Bowie WR, Roscoe D, Machan L, Black PC (2013) A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 189(4):1326–1331. doi:10.1016/j.juro.2012.09.121

    Article  CAS  PubMed  Google Scholar 

  28. Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M, Moon DA, O’Reilly M, Murphy D (2014) Sepsis and ‘superbugs’: Should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int 114(3):384–388. doi:10.1111/bju.12536

    PubMed  Google Scholar 

  29. Adibi M, Pearle MS, Lotan Y (2012) Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis. BJU Int 110(2 Pt 2):E86–E91. doi:10.1111/j.1464-410X.2011.10768.x

    Article  PubMed  Google Scholar 

  30. Cormio L, Berardi B, Callea A, Fiorentino N, Sblendorio D, Zizzi V, Traficante A (2002) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU Int 90(7):700–702

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard

This clinical study was approved by the institutional review board, and all patients provided informed consent prior to participation. All study procedures have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Author information

Authors and Affiliations

  1. Division of Urology, Department of Surgery, University of Utah Health Care, University of Utah, 30 N 1900 E, RM 3B420, Salt Lake City, UT, 84132, USA

    Stephen J. Summers, Darshan P. Patel, Blake D. Hamilton, William T. Lowrance & Andrew W. Southwick

  2. George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA

    Stephen J. Summers, Blake D. Hamilton, William T. Lowrance & Andrew W. Southwick

  3. Division of Epidemiology, University of Utah, Salt Lake City, UT, USA

    Angela P. Presson

  4. Department of Pathology, University of Utah, Salt Lake City, UT, USA

    Mark A. Fisher

  5. ARUP Laboratories, Salt Lake City, UT, USA

    Mark A. Fisher

Authors
  1. Stephen J. Summers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Darshan P. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Blake D. Hamilton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Angela P. Presson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mark A. Fisher
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. William T. Lowrance
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrew W. Southwick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew W. Southwick.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 183 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Summers, S.J., Patel, D.P., Hamilton, B.D. et al. An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy. World J Urol 33, 2001–2007 (2015). https://doi.org/10.1007/s00345-015-1571-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-015-1571-y

Keywords

Search

Navigation